Stonepine Capital, L.p. - Net Worth and Insider Trading
Stonepine Capital, L.p. Net Worth
The estimated net worth of Stonepine Capital, L.p. is at least $25 Million dollars as of 2024-12-01. Stonepine Capital, L.p. is the 10% Owner of Apollo Endosurgery Inc and owns about 2,185,426 shares of Apollo Endosurgery Inc (APEN) stock worth over $22 Million. Stonepine Capital, L.p. is also the 10% Owner of Novelion Therapeutics Inc and owns about 3,909,207 shares of Novelion Therapeutics Inc (NVLNF) stock worth over $3 Million. Details can be seen in Stonepine Capital, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stonepine Capital, L.p. has not made any transactions after 2019-12-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stonepine Capital, L.p.
Stonepine Capital, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stonepine Capital, L.p. owns 3 companies in total, including Novelion Therapeutics Inc (NVLNF) , Apollo Endosurgery Inc (APEN) , and Viveve Medical Inc (VIVE) .
Click here to see the complete history of Stonepine Capital, L.p.’s form 4 insider trades.
Insider Ownership Summary of Stonepine Capital, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NVLNF | Novelion Therapeutics Inc | 2019-12-12 | 10 percent owner |
| APEN | Apollo Endosurgery Inc | 2018-12-27 | 10 percent owner |
| VIVE | Viveve Medical Inc | 2015-05-14 | 10 percent owner |
Stonepine Capital, L.p. Latest Holdings Summary
Stonepine Capital, L.p. currently owns a total of 2 stocks. Among these stocks, Stonepine Capital, L.p. owns 2,185,426 shares of Apollo Endosurgery Inc (APEN) as of December 27, 2018, with a value of $22 Million and a weighting of 88.84%. Stonepine Capital, L.p. also owns 3,909,207 shares of Novelion Therapeutics Inc (NVLNF) as of December 12, 2019, with a value of $3 Million and a weighting of 11.16%.
Latest Holdings of Stonepine Capital, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APEN | Apollo Endosurgery Inc | 2018-12-27 | 2,185,426 | 10.00 | 21,854,260 |
| NVLNF | Novelion Therapeutics Inc | 2019-12-12 | 3,909,207 | 0.70 | 2,744,263 |
Holding Weightings of Stonepine Capital, L.p.
Stonepine Capital, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Stonepine Capital, L.p. has made a total of 0 transactions in Apollo Endosurgery Inc (APEN) over the past 5 years. The most-recent trade in Apollo Endosurgery Inc is the sale of 250,000 shares on December 27, 2018, which brought Stonepine Capital, L.p. around $750,000.
According to the SEC Form 4 filings, Stonepine Capital, L.p. has made a total of 2 transactions in Novelion Therapeutics Inc (NVLNF) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Novelion Therapeutics Inc is the acquisition of 6,242 shares on December 12, 2019, which cost Stonepine Capital, L.p. around $4,307.
Insider Trading History of Stonepine Capital, L.p.
- 1
Stonepine Capital, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Stonepine Capital, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stonepine Capital, L.p. is 4.14%. GuruFocus also compares Stonepine Capital, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Stonepine Capital, L.p. within 3 months outperforms 4 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stonepine Capital, L.p.'s insider trading performs compared to the benchmark.
Performance of Stonepine Capital, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.91 | | | | | |
| Relative Return to S&P 500(%) | 0.9 | | | | | |
Stonepine Capital, L.p. Ownership Network
Stonepine Capital, L.p. Owned Company Details
What does Novelion Therapeutics Inc do?
Who are the key executives at Novelion Therapeutics Inc?
Stonepine Capital, L.p. is the 10 percent owner of Novelion Therapeutics Inc. Other key executives at Novelion Therapeutics Inc include 10 percent owner Broadfin Healthcare Master Fund Ltd , 10 percent owner Broadfin Capital, Llc , and 10 percent owner Kevin Kotler .
Novelion Therapeutics Inc (NVLNF) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Novelion Therapeutics Inc (NVLNF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Novelion Therapeutics Inc (NVLNF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Novelion Therapeutics Inc (NVLNF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Novelion Therapeutics Inc Insider Transactions
Stonepine Capital, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Stonepine Capital, L.p.. You might contact Stonepine Capital, L.p. via mailing address: 919 Nw Bond Street, Suite 204, Bend Or 97703.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
